MarketInOut Stock Screener Log In | Sign Up
 

Daiichi Sankyo Co Ltd ADR

OTC • Healthcare • Drug Manufacturers - General • Quote as of 09/09/2026 16:00
Daiichi Sankyo Co Ltd ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization33,300 mln
Float1,820 mln
Earnings Date10/30/2026

EPS

0.88
Moderate

P / E

19.95
Moderately valued

Beneish M-Score

-2.25
Borderline

Relative Strength

44 / 100
Slightly lagging

Debt / Equity

0.29
Very low leverage

Pre-Tax Margin

11%
Moderate margin

Business Description

Daiichi Sankyo is a Japanese pharmaceutical company founded in 1899 and headquartered in Tokyo, with operations across the United States, Europe, and other global markets. The company develops and sells a broad range of medicines covering cancer, heart disease, diabetes, bone health, pain, and neurological conditions, along with vaccines for illnesses such as influenza and COVID-19. Among its best-known products are Enhertu, a cancer treatment used for several HER2-positive tumor types, and a growing portfolio of drugs targeting blood disorders, iron deficiency, and migraine. The company also works with outside partners to advance research and improve how new treatments are discovered and developed.

Key Fundamentals

EPS0.88
P/E19.95
ROE14.62
ROIC8.31
ROA6.40
Interest Cover22.20
EBITDA, mln2,185
EV / EBITDA15.17
EV / EBIT19.93
Revenue, mln14,257
EV / Revenue2.32

Financial Strength

Altman Z-Score3
Beneish M-Score-2.25
Price to Intrinsic Value2.12
Price to Lynch Fair Value0.89
Price to Graham Number1.97
Shiller PE Ratio37.68

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.55% 29 / 100   
1 Month -0.85% 43 / 100   
2 Months 8.46% 70 / 100   
6 Months -3.89% 44 / 100   
1 Year -30.24% 22 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us